The importance of including amyopathic dermatomyositis in the idiopathic inflammatory myositis spectrum

Clinical and Experimental Rheumatology

Volumn 31, Issue 1, 2013, Pages 128-134

  Ghazi, Elizabeth ^a,b,c   Sontheimer, Richard D ^d   Werth, Victoria P ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Amyopathic dermatomyositis; Connective tissue disease; Interstitial lung diseases

Indexed keywords

ANTIBODY; CADM 140 ANTIBODY; UNCLASSIFIED DRUG;

AMYOTOPHIC DERMATOMYOSITIS; ASIAN; CANCER RISK; CAUCASIAN; CLINICAL FEATURE; DERMATOMYOSITIS; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ETHNICITY; HUMAN; IDIOPATHIC DISEASE; INTERSTITIAL LUNG DISEASE; PREVALENCE; PRIORITY JOURNAL; PRURITUS; REVIEW; RISK ASSESSMENT; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

DERMATOMYOSITIS; DISEASE PROGRESSION; HUMANS; MYOSITIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; TIME FACTORS;

EID: 84874900771     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Bendewald MJ, Wetter DA, Li X, Davis MD: Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota. Arch Dermatol 2010;146:26-30.
2. Kang EH, Lee EB, Shin KC et al.: Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology 2005;44:1282-1286.
3. Mukae H, Ishimoto H, Sakamoto N et al.: Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis. Chest 2009;136:1341-1347.
4. Suda T, Fujisawa T, Enomoto N et al.: Interstitial lung diseases associated with amyopathic dermatomyositis. Eur Respir J 2006;28:1005-1012.
5. Ye S, Chen XX, Lu XY et al.: Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. Clin Rheumatol 2007;26:1647-1654.
6. Hamaguchi Y, Kuwana M, Hoshino K et al.: Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol 2011;147:391-398.
7. Gono T, Kawaguchi Y, Satoh T et al.: Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology 2010;49:1713-1719.
8. Sato S, Hirakata M, Kuwana M et al.: Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 2005;52:1571-1576.
9. Nagata K, Tomii K, Nanjo S, Kubota M, Tachikawa R, Nishio M: [Four cases of interstitial pneumonia associated with amyopathic dermatomyositis characterized by the anti-CADM-140 antibody]. Nihon Kokyuki Gakkai Zasshi 2011;49:30-36.
10. Franks AG, JR.: Skin manifestations of internal disease. Med Clin North Am 2009;93:1265-1282.
11. Klein RQ, Teal V, Taylor L, Troxel AB, Werth VP: Number, characteristics, and classification of patients with dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center. J Am Acad Dermatol 2007;57:937-943.
12. Gerami P, Schope JM, Mcdonald L, Walling HW, Sontheimer RD: A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol 2006;54:597-613.
13. Bohan A, Peter JB: Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403-407.
14. Bohan A, Peter JB: Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-347.
15. Arthritis And Allied Conditions: A Textbook of Rheumatology. 9th ed. 1979, Philadelphia, PA: Lea & Febiger.
16. Euwer RL, Sontheimer RD: Amyopathic dermatomyositis (dermatomyositis sine myositis). Presentation of six new cases and review of the literature. J Am Acad Dermatol 1991;24:959-966.
17. Sontheimer RD: Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 2002;46:626-636.
18. Gilliam JN, Sontheimer RD: Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol 1981;4:471-475.
19. Hochberg MC: The spectrum of systemic sclerosis--current concepts. Hosp Pract (Hosp Ed) 1981;16:61-67,70-72.
20. Amato AA, Griggs RC: Unicorns, dragons, polymyositis, and other mythological beasts. Neurology 2003;61:288-289.
21. Van Der Meulen MF, Bronner IM, Hoogendijk JE et al.: Polymyositis: an overdiagnosed entity. Neurology 2003;61:316-321.
22. Bronner IM, Linssen WH, Van Der Meulen MF, Hoogendijk JE, De Visser M: Polymyositis: an ongoing discussion about a disease entity. Arch Neurol 2004;61:132-135.
23. Leteurtre E, Hachulla E, Janin A, Hatron PY, Brouillard M, Devulder B: [Vascular manifestations of dermatomyositis and polymyositis. Clinical, capillaroscopic and histological aspects]. Rev Med Interne 1994;15:800-807.
24. Sultan SM, Isenberg DA: Re-classifying myositis. Rheumatology 2010;49:831-833.
25. Hoogendijk JE, Amato AA, Lecky BR et al.: 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 2004;14:337-345.
26. El-Azhary RA, Pakzad SY: Amyopathicdermatomyositis: retrospective review of 37 cases. J Am Acad Dermatol 2002;46:560-565.
27. Kovacs SO, Kovacs SC: Dermatomyositis. J Am Acad Dermatol 1998;39:899-920. quiz 921-2.
28. Dawkins MA et al.: Dermatomyositis: a dermatology-based case series. J Am Acad Dermatol 1998;38:397-404.
29. Caproni M, Cardinali C, Parodi A et al.: Amyopathic dermatomyositis: a review by the Italian Group of Immunodermatology. Arch Dermatol 2002;138:23-27.
30. Yu B: [A clinical analysis of cutaneous type dermatomyositis]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 1994;16:394-396.
31. Zhang ZL, Lai AY, Xu D, Chen YH, Tang FL: [Clinical analysis of 29 patients with clinically amyopathic dermatomyositis]. Zhonghua Yi Xue Za Zhi 2007;87:1345-1347.
32. Sontheimer RD: Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis. Curr Opin Rheumatol 1999;11:475-482.
33. Morganroth PA, Kreider ME, Okawa J, Taylor L, Werth VP: Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendations. Arch Dermatol 2010;146:729-738.
34. Marie I, Hachulla E, Chérin P et al.: Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 2002;47:614-622.
35. Cao H, Parikh TN, Zheng J: Amyopathic dermatomyositis or dermatomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis. Clin Rheumatol 2009;28:979-984.
36. Cottin V, Thivolet-Béjui F, Reynaudgaubert M et al.: Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J 2003;22:245-250.
37. Fathi M, Vikgren J, Boijsen M et al.: Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. Arthritis Rheum 2008;59:677-685.
38. Maldonado F, Patel RR, Iyer VN, YI ES, Ryu JH: Are respiratory complications common causes of death in inflammatory myopathies? An autopsy study. Respirology 2011;17:455-460.
39. Yamasaki Y, Yamada H, Ohkubo M et al.: Longterm survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan. J Rheumatol 2011;38:1636-1643.
40. Sato S, Hoshino K, Satoh T et al.: RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease. Arthritis Rheum 2009;60:2193-2200.
41. Sato S, Kuwana M: Clinically amyopathic dermatomyositis. Curr Opin Rheumatol 2010;22:639-643.
42. Tanizawa K, Handa T, Nakashima R et al.: HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody. Respir Med 2011;105:1380-1387.
43. Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L: The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study. J Am Acad Dermatol 2011;65:25-34.
44. Connors GR, Christopher-Stine L, Oddis CV, Danoff SK: Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest 2010;138:1464-1474.
45. Zahr ZA, Baer AN: Malignancy in myositis. Curr Rheumatol Rep 2011;13:208-215.
46. Hill CL, Zhang Y, Sigurgeirsson B et al.: Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001;357:96-100.
47. Sontheimer RD: Clinically amyopathic dermatomyositis: what can we now tell our patients? Arch Dermatol 2010;146:76-80.
48. Ang P, Sugeng MW, Chua SH: Classical and amyopathic dermatomyositis seen at the National Skin Centre of Singapore: a 3-year retrospective review of their clinical characteristics and association with malignancy. Ann Acad Med Singapore 2000; 29: 219-23.
49. Whitmore SE, Watson R, Rosenshein NB, Provost TT: Dermatomyositis sine myositis: association with malignancy. J Rheumatol 1996;23:101-105.
50. Azuma K, Yamada H, Ohkubo M et al.: Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis. Mod Rheumatol 2011; 21: 178-83.
51. Okiyama N, Kohsaka H, Ueda N et al.: Seborrheic area erythema as a common skin manifestation in Japanese patients with dermatomyositis. Dermatology 2008;217:374-377.
52. Goreshi R, Chock M, Foering K et al.: Quality of life in dermatomyositis. J Am Acad Dermatol 2011;65:1107-1116.
53. Klein RQ, Bangert CA, Costner M et al.: Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis. Br J Dermatol 2008;159:887-894.